Work

Erythropoietin as a macrophage-specific immunoregulatory switch with implications for oncology and transplantation

Year: 2025

Type: article

Abstract: Chiu DK, Zhang X, Cheng BY, et al. Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity. Science . 2025 Apr 25;388(6745) (see Fig. 1 )

Source: American Journal of Transplantation

DOI: 10.1016/j.ajt.2025.08.002

Authors: Paolo Cravedi, James M. Gardner

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,300

Funders: Burroughs Wellcome Fund, W. M. Keck Foundation, Kenneth Rainin Foundation, Parker Institute for Cancer Immunotherapy, National Institutes of Health, National Human Genome Research Institute, National Institute of Allergy and Infectious Diseases

Awards: Erythropoietin and trained immunity intransplantation, G9000070026, Single-cell Mapping Center for Human Regulatory Elements and Gene Activity

OpenAlex ID: W4413042430

FWCI:

Cites: 4

Cited by:

Related to: 10